– Standalone(1) 2008 financial objectives raised - MarketWatch

botulinum toxin - Google News -

– Standalone(1) 2008 financial objectives raised
MarketWatch - 1 hour ago
On March 17, 2008 — Medicis and Ipsen announced that Ipsen has submitted a Biologics License Application ("BLA") for the botulinum toxin type A,